1
AMGEN INC
COM
AMGN
AMGN
79,246
$21.3m7.17%
7.17%
Reduced Shares held: Q4 2022 16.2k, Q1 2023 91.2k, Q2 2023 117.2k, Q3 2023 79.2k
-38.0k
-38,000
-32.4%
2
INCYTE CORP
COM
INCY
INCY
358,454
$20.7m6.97%
6.97%
Unchanged Shares held: Q4 2022 229.0k, Q1 2023 279.0k, Q2 2023 358.5k, Q3 2023 358.5k
3
GILEAD SCIENCES INC
COM
GILD
GILD
233,584
$17.5m5.90%
5.90%
Added Shares held: Q4 2022 57.6k, Q1 2023 57.6k, Q2 2023 144.6k, Q3 2023 233.6k
+89.0k
+89,000
61.6%
4
INTRA-CELLULAR THERAPIES INC
COM
ITCI
ITCI
317,856
$16.5m5.57%
5.57%
Added Shares held: Q4 2022 221.9k, Q1 2023 257.9k, Q2 2023 176.9k, Q3 2023 317.9k
+141.0k
+141,000
79.7%
5
BIOMARIN PHARMACEUTICAL INC
COM
BMRN
BMRN
153,656
$13.6m4.58%
4.58%
Added Shares held: Q4 2022 43.7k, Q1 2023 58.7k, Q2 2023 58.7k, Q3 2023 153.7k
+95.0k
+95,000
162.0%
6
SUPERNUS PHARMACEUTICALS INC
COM
SUPN
SUPN
426,500
$11.8m3.96%
3.96%
Reduced Shares held: Q4 2022 383.5k, Q1 2023 423.5k, Q2 2023 523.5k, Q3 2023 426.5k
-97.0k
-97,000
-18.5%
7
VERA THERAPEUTICS INC
CL A
VERA
VERA
758,355
$10.4m3.50%
3.50%
Reduced Shares held: Q4 2022 281.3k, Q1 2023 1.0m, Q2 2023 975.2k, Q3 2023 758.4k
-216.9k
-216,872
-22.2%
8
BIOGEN INC
COM
BIIB
BIIB
40,200
$10.3m3.48%
3.48%
Added Shares held: Q4 2022 21.4k, Q1 2023 21.4k, Q2 2023 11.0k, Q3 2023 40.2k
+29.2k
+29,200
265.4%
9
HARMONY BIOSCIENCES HLDGS IN
COM
HRMY
HRMY
314,500
$10.3m3.47%
3.47%
Reduced Shares held: Q4 2022 264.5k, Q1 2023 570.5k, Q2 2023 570.5k, Q3 2023 314.5k
-256.0k
-256,000
-44.9%
10
MIRATI THERAPEUTICS INC
COM
MRTX
MRTX
216,000
$9.4m3.17%
3.17%
Reduced Shares held: Q4 2022 244.0k, Q1 2023 244.0k, Q2 2023 260.0k, Q3 2023 216.0k
-44.0k
-44,000
-16.9%
11
ULTRAGENYX PHARMACEUTICAL IN
COM
RARE
RARE
250,052
$8.9m3.00%
3.00%
Added Shares held: Q4 2022 174.1k, Q1 2023 264.1k, Q2 2023 80.1k, Q3 2023 250.1k
+170.0k
+170,000
212.4%
12
UNIQURE NV
SHS
QURE
QURE
1,241,500
$8.3m2.81%
2.81%
Added Shares held: Q4 2022 631.5k, Q1 2023 478.5k, Q2 2023 15.5k, Q3 2023 1.2m
+1.2m
+1,226,000
7909.7%
13
AURINIA PHARMACEUTICALS INC
COM
AUPH
AUPH
1,040,530
$8.1m2.72%
2.72%
Added Shares held: Q4 2022 573.5k, Q1 2023 573.5k, Q2 2023 573.5k, Q3 2023 1.0m
+467.0k
+467,000
81.4%
14
UNITED THERAPEUTICS CORP DEL
COM
UTHR
UTHR
33,959
$7.7m2.58%
2.58%
Reduced Shares held: Q4 2022 15.0k, Q1 2023 28.5k, Q2 2023 52.8k, Q3 2023 34.0k
-18.8k
-18,800
-35.6%
15
VERTEX PHARMACEUTICALS INC
COM
VRTX
VRTX
21,000
$7.3m2.46%
2.46%
Unchanged Shares held: Q4 2022 0, Q1 2023 33.0k, Q2 2023 21.0k, Q3 2023 21.0k
16
REGENERON PHARMACEUTICALS
COM
REGN
REGN
8,847
$7.3m2.45%
2.45%
Reduced Shares held: Q4 2022 11.2k, Q1 2023 11.2k, Q2 2023 27.0k, Q3 2023 8.8k
-18.2k
-18,153
-67.2%
17
ILLUMINA INC
COM
ILMN
ILMN
50,500
$6.9m2.34%
2.34%
Unchanged Shares held: Q4 2022 46.5k, Q1 2023 26.5k, Q2 2023 50.5k, Q3 2023 50.5k
18
ALNYLAM PHARMACEUTICALS INC
COM
ALNY
ALNY
36,800
$6.5m2.20%
2.20%
Reduced Shares held: Q4 2022 38.0k, Q1 2023 46.6k, Q2 2023 81.6k, Q3 2023 36.8k
-44.8k
-44,800
-54.9%
19
AMYLYX PHARMACEUTICALS INC
COM
AMLX
AMLX
295,000
$5.4m1.82%
1.82%
Added Shares held: Q4 2022 0, Q1 2023 0, Q2 2023 25.0k, Q3 2023 295.0k
+270.0k
+270,000
1080.0%
20
KRYSTAL BIOTECH INC
COM
KRYS
KRYS
46,092
$5.3m1.80%
1.80%
Added Shares held: Q4 2022 45.0k, Q1 2023 61.0k, Q2 2023 45.9k, Q3 2023 46.1k
+147
+147
0.3%
21
KARUNA THERAPEUTICS INC
COM
COM
30,500
$5.2m1.74%
1.74%
Added Shares held: Q4 2022 0, Q1 2023 11.0k, Q2 2023 25.7k, Q3 2023 30.5k
+4.8k
+4,800
18.7%
22
AXSOME THERAPEUTICS INC
COM
AXSM
AXSM
58,300
$4.1m1.37%
1.37%
Unchanged Shares held: Q4 2022 0, Q1 2023 0, Q2 2023 58.3k, Q3 2023 58.3k
23
ERASCA INC
COM
ERAS
ERAS
1,926,000
$3.8m1.28%
1.28%
Added Shares held: Q4 2022 0, Q1 2023 1.4m, Q2 2023 1.4m, Q3 2023 1.9m
+500.0k
+500,000
35.1%
24
ACADIA PHARMACEUTICALS INC
COM
ACAD
ACAD
179,702
$3.7m1.26%
1.26%
Added Shares held: Q4 2022 100.0k, Q1 2023 216.0k, Q2 2023 151.0k, Q3 2023 179.7k
+28.7k
+28,702
19.0%
25
REVANCE THERAPEUTICS INC
COM
RVNC
RVNC
288,726
$3.3m1.11%
1.11%
Unchanged Shares held: Q4 2022 120.0k, Q1 2023 183.0k, Q2 2023 288.7k, Q3 2023 288.7k
26
NEUROCRINE BIOSCIENCES INC
COM
NBIX
NBIX
28,877
$3.2m1.09%
1.09%
Reduced Shares held: Q4 2022 0, Q1 2023 0, Q2 2023 68.9k, Q3 2023 28.9k
-40.0k
-40,000
-58.1%
27
SAREPTA THERAPEUTICS INC
COM
SRPT
SRPT
26,700
$3.2m1.09%
1.09%
Added Shares held: Q4 2022 0, Q1 2023 0, Q2 2023 18.8k, Q3 2023 26.7k
+7.9k
+7,900
42.0%
28
ROCKET PHARMACEUTICALS INC
COM
RCKT
RCKT
156,000
$3.2m1.08%
1.08%
Unchanged Shares held: Q4 2022 63.0k, Q1 2023 63.0k, Q2 2023 156.0k, Q3 2023 156.0k
29
DENALI THERAPEUTICS INC
COM
DNLI
DNLI
154,000
$3.2m1.07%
1.07%
Reduced Shares held: Q4 2022 38.0k, Q1 2023 86.6k, Q2 2023 188.0k, Q3 2023 154.0k
-34.0k
-34,000
-18.1%
30
ASTRAZENECA PLC
SPONSORED ADR
SPONSORED ADR
46,500
$3.1m1.06%
1.06%
New Shares held: Q4 2022 65.0k, Q1 2023 65.0k, Q2 2023 0, Q3 2023 46.5k
31
XENON PHARMACEUTICALS INC
COM
XENE
XENE
91,500
$3.1m1.05%
1.05%
Added Shares held: Q4 2022 25.5k, Q1 2023 25.5k, Q2 2023 25.5k, Q3 2023 91.5k
+66.0k
+66,000
258.8%
32
CRISPR THERAPEUTICS AG
NAMEN AKT
CRSP
CRSP
63,000
$2.9m0.96%
0.96%
New Shares held: Q4 2022 34.2k, Q1 2023 34.2k, Q2 2023 0, Q3 2023 63.0k
33
MADRIGAL PHARMACEUTICALS INC
COM
MDGL
MDGL
18,300
$2.7m0.90%
0.90%
Unchanged Shares held: Q4 2022 0, Q1 2023 0, Q2 2023 18.3k, Q3 2023 18.3k
34
LEGEND BIOTECH CORP
SPONSORED ADS
LEGN
LEGN
38,000
$2.6m0.86%
0.86%
Unchanged Shares held: Q4 2022 38.0k, Q1 2023 38.0k, Q2 2023 38.0k, Q3 2023 38.0k
35
HALOZYME THERAPEUTICS INC
COM
HALO
HALO
62,200
$2.4m0.80%
0.80%
Reduced Shares held: Q4 2022 0, Q1 2023 45.5k, Q2 2023 95.5k, Q3 2023 62.2k
-33.3k
-33,300
-34.9%
36
MARINUS PHARMACEUTICALS INC
COM NEW
MRNS
MRNS
290,000
$2.3m0.79%
0.79%
Added Shares held: Q4 2022 0, Q1 2023 0, Q2 2023 90.0k, Q3 2023 290.0k
+200.0k
+200,000
222.2%
37
BEIGENE LTD
SPONSORED ADR
ONC
ONC
12,700
$2.3m0.77%
0.77%
Added Shares held: Q4 2022 15.7k, Q1 2023 22.7k, Q2 2023 8.7k, Q3 2023 12.7k
+4.0k
+4,000
46.0%
38
JAZZ PHARMACEUTICALS PLC
SHS USD
JAZZ
JAZZ
17,200
$2.2m0.75%
0.75%
Unchanged Shares held: Q4 2022 17.2k, Q1 2023 17.2k, Q2 2023 17.2k, Q3 2023 17.2k
39
MIRUM PHARMACEUTICALS INC
COM
MIRM
MIRM
67,500
$2.1m0.72%
0.72%
Unchanged Shares held: Q4 2022 67.5k, Q1 2023 67.5k, Q2 2023 67.5k, Q3 2023 67.5k
40
IOVANCE BIOTHERAPEUTICS INC
COM
IOVA
IOVA
445,000
$2.0m0.68%
0.68%
Added Shares held: Q4 2022 56.0k, Q1 2023 56.0k, Q2 2023 65.0k, Q3 2023 445.0k
+380.0k
+380,000
584.6%
41
IONIS PHARMACEUTICALS INC
COM
IONS
IONS
43,000
$1.9m0.66%
0.66%
Unchanged Shares held: Q4 2022 0, Q1 2023 43.0k, Q2 2023 43.0k, Q3 2023 43.0k
42
ZAI LAB LTD
ADR
ZLAB
ZLAB
78,958
$1.9m0.65%
0.65%
Unchanged Shares held: Q4 2022 79.0k, Q1 2023 79.0k, Q2 2023 79.0k, Q3 2023 79.0k
43
GENMAB A/S
SPONSORED ADS
GMAB
GMAB
44,300
$1.6m0.53%
0.53%
New Shares held: Q4 2022 0, Q1 2023 88.0k, Q2 2023 0, Q3 2023 44.3k
44
CELLDEX THERAPEUTICS INC NEW
COM NEW
CLDX
CLDX
48,099
$1.3m0.45%
0.45%
Unchanged Shares held: Q4 2022 0, Q1 2023 0, Q2 2023 48.1k, Q3 2023 48.1k
45
COGENT BIOSCIENCES INC
COM
COGT
COGT
135,000
$1.3m0.44%
0.44%
New Shares held: Q4 2022 0, Q1 2023 0, Q2 2023 0, Q3 2023 135.0k
46
DYNE THERAPEUTICS INC
COM
DYN
DYN
137,751
$1.2m0.41%
0.41%
Reduced Shares held: Q4 2022 641.1k, Q1 2023 433.8k, Q2 2023 300.8k, Q3 2023 137.8k
-163.0k
-163,000
-54.2%
47
NOVOCURE LTD
ORD SHS
NVCR
NVCR
74,000
$1.2m0.40%
0.40%
Added Shares held: Q4 2022 32.0k, Q1 2023 32.0k, Q2 2023 32.0k, Q3 2023 74.0k
+42.0k
+42,000
131.2%
48
AMICUS THERAPEUTICS INC
COM
FOLD
FOLD
90,000
$1.1m0.37%
0.37%
New Shares held: Q4 2022 0, Q1 2023 0, Q2 2023 0, Q3 2023 90.0k
49
CYTOKINETICS INC
COM NEW
CYTK
CYTK
37,000
$1.1m0.37%
0.37%
Unchanged Shares held: Q4 2022 0, Q1 2023 0, Q2 2023 37.0k, Q3 2023 37.0k
50
GUARDANT HEALTH INC
COM
GH
GH
36,500
$1.1m0.36%
0.36%
Unchanged Shares held: Q4 2022 74.5k, Q1 2023 74.5k, Q2 2023 36.5k, Q3 2023 36.5k
51
INSMED INC
COM PAR $.01
INSM
INSM
40,100
$1.0m0.34%
0.34%
Unchanged Shares held: Q4 2022 40.1k, Q1 2023 40.1k, Q2 2023 40.1k, Q3 2023 40.1k
52
BLUEPRINT MEDICINES CORP
COM
BPMC
BPMC
20,000
$1.0m0.34%
0.34%
New Shares held: Q4 2022 0, Q1 2023 0, Q2 2023 0, Q3 2023 20.0k
53
AKERO THERAPEUTICS INC
COM
AKRO
AKRO
18,489
$935.2k0.32%
0.32%
Reduced Shares held: Q4 2022 0, Q1 2023 0, Q2 2023 78.5k, Q3 2023 18.5k
-60.0k
-60,000
-76.4%
54
KEZAR LIFE SCIENCES INC
COM
COM
703,825
$830.5k0.28%
0.28%
New Shares held: Q4 2022 0, Q1 2023 0, Q2 2023 0, Q3 2023 703.8k
55
INTELLIA THERAPEUTICS INC
COM
NTLA
NTLA
24,000
$757.9k0.26%
0.26%
Unchanged Shares held: Q4 2022 24.0k, Q1 2023 24.0k, Q2 2023 24.0k, Q3 2023 24.0k
56
PROTHENA CORP PLC
SHS
PRTA
PRTA
15,000
$722.9k0.24%
0.24%
New Shares held: Q4 2022 0, Q1 2023 0, Q2 2023 0, Q3 2023 15.0k
57
AGIOS PHARMACEUTICALS INC
COM
AGIO
AGIO
24,000
$593.5k0.20%
0.20%
Unchanged Shares held: Q4 2022 0, Q1 2023 0, Q2 2023 24.0k, Q3 2023 24.0k
58
BEAM THERAPEUTICS INC
COM
BEAM
BEAM
23,500
$564.7k0.19%
0.19%
Unchanged Shares held: Q4 2022 23.5k, Q1 2023 23.5k, Q2 2023 23.5k, Q3 2023 23.5k
59
VENTYX BIOSCIENCES INC
COM
VTYX
VTYX
15,000
$520.6k0.18%
0.18%
Unchanged Shares held: Q4 2022 0, Q1 2023 15.0k, Q2 2023 15.0k, Q3 2023 15.0k
60
VIR BIOTECHNOLOGY INC
COM
VIR
VIR
47,000
$439.9k0.15%
0.15%
New Shares held: Q4 2022 0, Q1 2023 0, Q2 2023 0, Q3 2023 47.0k
61
I MAB
SPONSORED ADS
NBP
NBP
310,499
$409.9k0.14%
0.14%
Unchanged Shares held: Q4 2022 310.5k, Q1 2023 310.5k, Q2 2023 310.5k, Q3 2023 310.5k
62
PTC THERAPEUTICS INC
COM
PTCT
PTCT
17,000
$380.6k0.13%
0.13%
Unchanged Shares held: Q4 2022 144.0k, Q1 2023 93.0k, Q2 2023 17.0k, Q3 2023 17.0k
63
ARVINAS INC
COM
ARVN
ARVN
17,000
$333.5k0.11%
0.11%
Unchanged Shares held: Q4 2022 17.0k, Q1 2023 17.0k, Q2 2023 17.0k, Q3 2023 17.0k
64
PROTAGONIST THERAPEUTICS INC
COM
PTGX
PTGX
19,900
$331.9k0.11%
0.11%
Unchanged Shares held: Q4 2022 0, Q1 2023 0, Q2 2023 19.9k, Q3 2023 19.9k
65
RELMADA THERAPEUTICS INC
COM
RLMD
RLMD
10,000
$30.0k0.01%
0.01%
Unchanged Shares held: Q4 2022 10.0k, Q1 2023 10.0k, Q2 2023 10.0k, Q3 2023 10.0k